Fentanyl vs. Dexmedetomidine for awake fiberoptic intubation: A comparison.

Background: Ever since the dawn of modern medical core Surgical practice, the tracheal intubation techniques in Anaesthetic care has rapidly evolved and still evolving into newer modalities. The importance of tracheal intubation in securing airway is obvious and needs no emphasis. Methods: Between February 2022 to January 2023, researchers from the Department of Anesthesiology, Kamineni Academy of Medical Sciences and Research Centre, LB Nagar, Hyderabad, Telangana, India, conducted this clinical trial. The study was approved by the hospital's ethics review board. All patients provided their written informed permission. Sixty patients receiving Awake Fiberoptic Intubation were included, all of whom had been scheduled for elective surgery. Results: An annexed master chart includes the ages and sexes of all study participants, as well as their weights, ASA-PS classifications, cough scores, post-intubation scores, Ramsay sedation scores, oxygen saturations, heart rates and mean arterial pressures before and after intubation. Conclusion: We found that Awake Fiberoptic Intubation with Inj. Dexmedetomidine was associated with improved sedation, intubating conditions and tolerance compared to AFI with Inj. Fentanyl. [ABSTRACT FROM AUTHOR]